Author:
Ellmark Peter,Woolfson Adrian,Belov Larissa,Christopherson Richard I.
Reference17 articles.
1. 1. Schoniger-Hekele M, Muller C (2006) The combined elevation of tumour markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis. Dig Dis Sci 51:338–345
2. 2. Louhimo J, Finne P, Alfthan H, Stenman UH, Haglund C (2002) Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies. Anticancer Res 22:1759–1764
3. 3. Woolfson A, Ellmark P, Chrisp JS, Scott MA, Christopherson RI (2006) The application of CD antigen proteomics to pharmacogenomics. Pharmacogenomics 7:759–771
4. 4. Borrebaeck CA (2006) Antibody microarray-based oncoproteomics. Expert Opin Biol Ther 6:833–838
5. 5. Lal SP, Christopherson RI, dos Remedios CG (2002) Antibody arrays: An embryonic but rapidly growing technology. Drug Discov Today 7:S143–S149
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献